Welcome to our dedicated page for ASTRONICS SEC filings (Ticker: ATRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ASTRONICS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ASTRONICS's regulatory disclosures and financial reporting.
Astronics Corp President and CEO Peter J. Gundermann reported equity award activity. On March 3, 2026, he exercised 13,550 restricted stock units, receiving the same number of $.01 par value common shares at a stated price of $81.35 per share, and ended with 93,967.608 common shares held directly. To cover withholding taxes, 3,489 common shares were withheld by Astronics Corp.
Footnotes explain that each restricted stock unit converts into one common share at settlement. Several performance-based restricted stock unit awards depend on Astronics Corp.'s average annual adjusted EBITDA for periods spanning 2023–2028; between 50% and 150% of target units may vest on February 23, 2027, February 27, 2028, and February 19, 2029, based on actual performance. One grant covering the 2023–2025 period vested at 100% of the target on February 23, 2026.
Astronics Corp director Robert T. Brady reported several equity award transactions. On February 26, 2026, he exercised stock options for 4,000 options and another 1,290 options, receiving common and Class B shares of Astronics as noted in the footnotes as shares acquired upon exercise of stock options.
Following these exercises, his direct holdings increased to 89,063 shares of $.01 par value common stock and 176,366 shares of $.01 par value Class B stock. In a separate transaction coded “F”, 1,539 common shares were withheld by Astronics Corp to cover the option exercise price or related tax obligations, rather than being sold on the open market.
Astronics Corporation filed its annual report detailing 2025 operations in its Aerospace and Test Systems segments, both serving global aerospace, defense, and electronics markets. Boeing remained a key customer, accounting for 10.4% of sales in 2025, underscoring significant customer concentration risk.
The company expanded its Aerospace segment with two acquisitions: Envoy Aerospace for approximately $8.3 million and Germany-based Bühler Motor Aviation for about $18.0 million. It also refinanced its capital structure, replacing a $220.0 million asset-based revolver with a $300.0 million senior secured revolving credit facility and issuing $225.0 million of 2031 Convertible Notes while repurchasing most of its 2030 notes.
Backlog grew to $674.5 million at December 31, 2025, driven mainly by recovering commercial transport and general aviation demand. The company employed about 2,700 full-time staff and highlights extensive risk disclosures, including heavy aerospace cyclicality, supply chain and inflation pressures, government contracting exposure, and ongoing patent litigation with Lufthansa Technik that has already led to monetary payments and could result in substantial additional losses.
Astronics Corporation delivered a strong turnaround in 2025, capped by a record fourth quarter. Fourth quarter sales rose 15.1% to $240.1 million, driven by record Aerospace revenue of $219.6 million, and net income reached $29.6 million, or $0.78 per diluted share, versus a prior-year loss.
For 2025, sales grew to $862.1 million from $795.4 million and net income improved to $29.4 million from a $16.2 million loss. Adjusted EBITDA for the year increased to $134.5 million with margin expanding to 15.6%. The company ended 2025 with a record backlog of $674.5 million and generated $74.8 million of cash from operations.
Astronics maintained its 2026 revenue outlook of $950 million to $990 million, implying about 13% growth at the midpoint, supported by strong Aerospace demand, the Bühler Motor Aviation acquisition, and expectations for improved profitability as Test Systems volume ramps.
GUNDERMANN PETER J reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp President and CEO Peter J. Gundermann received a grant of 12,150 restricted stock units on February 19, 2026. Each unit represents the right to receive one share of common stock at settlement.
The vesting of this award depends on Astronics Corp.'s average annual adjusted EBITDA for the period from January 1, 2023 through December 31, 2025. Between 75% and 115% of the target 12,150 units may vest on February 23, 2026, with the final vesting percentage determined by actual performance over that period.
Astronics Corporation director Robert T. Brady acquired 1,533 shares of $.01 par value common stock on a grant/award basis on February 19, 2026. The stock bonus was compensation for his service as a director and increased his directly held common shares to 86,602. As of the same date, he also directly held 175,076 shares of $.01 par value Class B stock and several blocks of stock options with reported remaining option balances.
Astronics Corporation director Neil Y. Kim reported an equity award. On February 19, 2026, he acquired 1,533 shares of $.01 par value common stock as a stock bonus award for his service as a director. After this grant, he directly holds 44,056 common shares.
Keane Robert S reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Robert S. Keane received a stock bonus of 1,533 shares of $.01 par value common stock on February 19, 2026 as compensation for board service, at a stated price of $0.0000 per share.
After this grant, his directly held common stock position increased to 13,934 shares. The filing also reports indirect holdings of $.01 par value Class B stock, including 206,886 shares held through a trust for multiple potential beneficiaries and 208,199 shares held through Boston & Saranac LLC, which is owned by a trust whose beneficiaries include Keane and his spouse.
JOHNSON WARREN C reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Warren C. Johnson received a stock bonus award of 1,533 shares of $.01 par value common stock on 2026-02-19. The shares were granted as compensation for his service as a director, at a reported price of $0.00 per share.
After this award, Johnson directly owns 49,756 common shares and continues to hold multiple option positions in Astronics stock.
O'Brien Linda reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp director Linda O'Brien received a stock bonus award of 1,533 shares of $.01 par value common stock as compensation for her service as a director. The award was recorded at a price of $0.00 per share and increased her directly owned holdings to 21,372 shares.
The filing also notes 1,200 shares held indirectly through her spouse, reflecting additional ownership associated with her household.